A message from our sponsor.
We must protect American leadership in the life sciences and avoid damaging drug pricing policies. Meanwhile, China is making significant strides in clinical trials, drug approvals and new breakthroughs. Now is the time to strengthen American innovation, not hinder it. Learn more.